Inducible expression of p57KIP2 inhibits glioma cell motility and invasion

Journal of Neuro-Oncology

Volumn 68, Issue 3, 2004, Pages 217-223

  Sakai, K ^a   Peraud, A ^d   Mainprize, T ^d   Nakayama, J ^b   Tsugu, A ^c   Hongo, K ^a   Kobayashi, S ^a   Rutka, James T ^d  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Invasion assay; Motility assay; p57KIP2

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYCLIN DEPENDENT KINASE INHIBITOR; DOXYCYCLINE; FIBRONECTIN; GOLD; LAMININ; PROTEIN P57; SCLEROPROTEIN; TETRACYCLINE; CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; NUCLEAR PROTEIN;

ARTICLE; CELL ASSAY; CELL INVASION; CELL KINETICS; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENETIC STABILITY; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PHAGOCYTOSIS; PHENOTYPE; PROTEIN EXPRESSION; WESTERN BLOTTING; CANCER INVASION; CELL DIVISION; CELL MOTION; CENTRAL NERVOUS SYSTEM TUMOR; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; TRANSFECTION;

EID: 3042814308     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000033380.08940.c8     Document Type: Article

References (26)

1. Holland EC: Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 97: 6242-6244, 2000
2. Louis DN, Holland EC, Cairncross JG: Glioma classification: a molecular reappraisal. Am J Pathol 159: 779-786, 2001
3. Dirks PB, Hubbard SL, Murakami M, Rutka JT: Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J Neuropathol Exp Neurol 56: 291-300, 1997
4. Dirks PB, Rutka JT: Current concepts in neuro-oncology: the cell cycle - a review. Neurosurgery 40: 1000-1013, 1997 (discussion 1013-1005)
5. Tsugu A, Sakai K, Dirks PB, Jung S, Weksberg R, Fei YL, Mondal S, Ivanchuk S, Ackerley C, Hamel PA et al.: Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence. Am J Pathol 157: 919-932, 2000
6. Mainprize TG, Taylor MD, Rutka JT, Dirks PB: Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective. J Neurooncol 51: 205-218, 2001
7. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9: 650-662, 1995
8. Giese A, Loo MA, Rief MD, Tran N, Berens ME: Substrates for astrocytoma invasion. Neurosurgery 37: 294-301, 1995 (discussion 301-292)
9. Yoshizato K, Zapf S, Westphal M, Berens ME, Giese A: Thromboxane synthase inhibitors induce apoptosis in migration-arrested glioma cells. Neurosurgery 50: 343-354, 2002
10. Westermark B, Ponten J, Hugosson R: Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand [A] 81: 791-805, 1973
11. Baron U, Gossen M, Bujard H: Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 25, 2723-2729, 1997
12. Gossen M, Bujard H: Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 36: 153-173, 2002
13. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551, 1992
14. Gossen M, Bujard H: Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary. Biotechniques 19: 213-216, 1995. (Discussion 216-217)
15. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769, 1995
16. Resnitzky D, Gossen M, Bujard H, Reed SI: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669-1679, 1994
17. Albrecht-Buehler G: The phagokinetic tracks of 3T3 cells. Cell 11: 395-404, 1977
18. Albrecht-Buehler G: Phagokinetic tracks of 3T3 cells: parallels between the orientation of track segments and of cellular structures which contain actin or tubulin. Cell 12: 333-339, 1977
19. Albrecht-Buehler G: The tracks of moving cells. Sci Am 238, 68-76, 1978
20. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987
21. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME: Dichotomy of astrocytoma, migration and proliferation. Int J Cancer 67: 275-282, 1996
22. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM et al.: Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53: 161-176, 2001
23. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Kaczmarek E, Ponce F, Coons SW, Giese A, Seiler RW, Berens ME: Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma, cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res 7: 2480-2489, 2001
24. Ito Y, Takeda T, Sakon M, Tsujimoto M, Monden M, Matsuura N: Expression of p57/Kip2 protein in hepatocellular carcinoma. Oncology 61: 221-225, 2001
25. Nakai S, Masaki T, Shiratori Y, Ohgi T, Morishita A, Kurokohchi K, Watanabe S, Kuriyama S: Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Int J Oncol 20: 769-775, 2002
26. Rosenberg E, Demopoulos RI, Zeleniuch-Jacquotte A, Yee H, Sorich J, Speyer JL, Newcomb EW: Expression of cell cycle regulators p57(KIP2), cyclin D1, cyclin E in epithelial ovarian tumors and survival. Hum Pathol 32: 808-813, 2001